Larry Lin

Mr. Lin’s experience in the investment industry began in 1998 when he joined Engemann.
Mr. Lin is the primary analyst covering the health care industry for Engemann and specializes in pharmaceuticals, biotechnology, medical devices and pharmacy benefit management (PBM) companies.
He holds a Bachelor of Science degree in biomedical engineering from the University of Southern California.
Mr. Lin has earned the right to use the Chartered Financial Analyst designation and is a member of The Los Angeles Society of Financial Analysts (LASFA).